LXRXNasdaq United States
Market cap
$1.097 B
$2.47 +4.66%
Close of 7 Aug 2026
Revenue
$49.8M
#2743 by revenue
Earnings
-$50.3M
Loss-making
Shares outstanding
444,955,934
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Lexicon Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.